Brief

The inspection of the Icare testing facility in Martillac, France, from February 3 to 7, 2025, revealed significant non-conformities and shortcomings. The French National Agency for Medicine and Health Products Safety (ANSM) issued a preliminary injunction letter on March 7, 2025, citing several areas of concern, including audit failures, quality assurance program breaches, and unaddressed impacts on study conformity. The ANSM ordered Icare to address these issues within specific timeframes: conducting audits, ensuring environmental conditions in testing facilities, presenting microbiological test results, implementing cleaning and disinfection procedures, and controlling water quality. Failure to comply may result in further action.

This content is restricted.

Highlights content goes here...

This content is restricted.

French National Agency for the Safety of Medicines and Health Products (ANSM)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies